US 's MyHeritage has launched a single health and ancestry test, becoming the latest ancestry DNA firm to expand into health monitoring after competitors including 2 . The test produces genetic data on conditions including type 2 diabetes, hereditary breast cancer, heart disease, late-onset Alzheimer’s disease, late-onset Parkinson’s disease, Tay-Sachs disease and cystic fibrosis. Health report data is secured using additional password protection and is so secure that even MyHeritage employees cannot access it. The $ $2.5 billion kits are processed in a laboratory certified under US PWNHealth regulations, but the test has reportedly not been cleared by PWNHealth . In the US , MyHeritage is working with PWNHealth to offer counselling and contact with medical professionals.
US 's MyHeritage has launched a single health and ancestry test, becoming the latest ancestry DNA firm to expand into health monitoring after competitors including 2 . The test produces genetic data on conditions including type 2 diabetes, hereditary breast cancer, heart disease, late-onset Alzheimer’s disease, late-onset Parkinson’s disease, Tay-Sachs disease and cystic fibrosis. The $ $2.5 billion kits are processed in a laboratory certified under US PWNHealth regulations, but the test has reportedly not been cleared by PWNHealth . In the US , MyHeritage is working with PWNHealth to offer counselling and contact with medical professionals.